Anika Therapeutics, Inc. 4
4 · Anika Therapeutics, Inc. · Filed Feb 5, 2015
Insider Transaction Report
Form 4
LUPPINO FRANCESCO J
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-02-03+3,100Exercise: $39.69Exp: 2025-02-03→ Common Stock (3,100 underlying)
Footnotes (1)
- [F1]The stock options vest in four equal annual installments beginning February 3, 2016.